Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-25-037163

Options or other derivatives

  • Chief Executive Officer acquired 65,886 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Robinson Chandler · Chief Executive Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-12-02 Grant or award : show line 1 in the form Stock Options +16,753 16,753 D
2025-12-02 Grant or award : show line 2 in the form Restricted Stock Units +49,133 121,732 D
Loading xslF345X05/rdgdoc.xml…